MA51565A - Nouveaux procédés et intermédiaires pour la préparation de stimulateurs de la guanylate cyclase soluble - Google Patents
Nouveaux procédés et intermédiaires pour la préparation de stimulateurs de la guanylate cyclase solubleInfo
- Publication number
- MA51565A MA51565A MA051565A MA51565A MA51565A MA 51565 A MA51565 A MA 51565A MA 051565 A MA051565 A MA 051565A MA 51565 A MA51565 A MA 51565A MA 51565 A MA51565 A MA 51565A
- Authority
- MA
- Morocco
- Prior art keywords
- intermediaries
- preparation
- guanylate cyclase
- new processes
- soluble guanylate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
- C07C237/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
- C07C237/08—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/235—Saturated compounds containing more than one carboxyl group
- C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Health & Medical Sciences (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Chemistry (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862615678P | 2018-01-10 | 2018-01-10 | |
| PCT/CN2018/076982 WO2019161534A1 (en) | 2018-02-22 | 2018-02-22 | Novel processes and intermediates for preparation of soluble guanylate cyclase stimulators |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA51565A true MA51565A (fr) | 2020-11-18 |
Family
ID=65279655
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA051565A MA51565A (fr) | 2018-01-10 | 2019-01-10 | Nouveaux procédés et intermédiaires pour la préparation de stimulateurs de la guanylate cyclase soluble |
| MA71753A MA71753A (fr) | 2018-01-10 | 2019-01-10 | Nouveaux procédés et intermédiaires pour la préparation de stimulateurs de guanylate cyclase soluble |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA71753A MA71753A (fr) | 2018-01-10 | 2019-01-10 | Nouveaux procédés et intermédiaires pour la préparation de stimulateurs de guanylate cyclase soluble |
Country Status (16)
| Country | Link |
|---|---|
| US (5) | US11274096B2 (OSRAM) |
| EP (3) | EP4249469A3 (OSRAM) |
| JP (2) | JP7357621B2 (OSRAM) |
| KR (3) | KR20250048609A (OSRAM) |
| CN (3) | CN111902410B (OSRAM) |
| AU (3) | AU2019206560B2 (OSRAM) |
| CA (1) | CA3087943A1 (OSRAM) |
| CL (3) | CL2020001814A1 (OSRAM) |
| ES (1) | ES2963447T3 (OSRAM) |
| IL (3) | IL314714A (OSRAM) |
| JO (1) | JOP20200165A1 (OSRAM) |
| MA (2) | MA51565A (OSRAM) |
| MX (3) | MX2020007364A (OSRAM) |
| SG (1) | SG11202006311SA (OSRAM) |
| TW (2) | TWI888947B (OSRAM) |
| WO (1) | WO2019140095A1 (OSRAM) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2963563T3 (es) | 2016-07-07 | 2024-03-27 | Cyclerion Therapeutics Inc | Procesos novedosos para preparar estimuladores de guanilato ciclasa soluble |
| EP4249469A3 (en) | 2018-01-10 | 2023-12-27 | Cyclerion Therapeutics, Inc. | Novel processes and intermediates for the preparation of soluble guanylate cyclase stimulators |
| WO2024131860A1 (zh) * | 2022-12-21 | 2024-06-27 | 广东东阳光药业股份有限公司 | 氟取代的吲唑化合物的晶型及其用途 |
| AU2023412228A1 (en) * | 2022-12-21 | 2025-07-03 | Sunshine Lake Pharma Co., Ltd. | Crystal form of fluorine-substituted indazole compound and use thereof |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012003405A1 (en) * | 2010-06-30 | 2012-01-05 | Ironwood Pharmaceuticals, Inc. | Sgc stimulators |
| SI2970243T1 (sl) * | 2013-03-15 | 2020-04-30 | Cyclerion Therapeutics, Inc. | SGC stimulatorji |
| EP3094327A1 (en) * | 2014-01-13 | 2016-11-23 | Ironwood Pharmaceuticals, Inc. | USE OF sGC STIMULATORS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS |
| JP2017527605A (ja) * | 2014-09-17 | 2017-09-21 | アイアンウッド ファーマシューティカルズ インコーポレイテッド | ｓＧＣ刺激剤 |
| CA2959757A1 (en) | 2014-09-17 | 2016-03-24 | Ironwood Pharmaceuticals, Inc. | Pyrazole derivatives as sgc stimulators |
| EA201891315A1 (ru) * | 2015-11-30 | 2018-12-28 | Айронвуд Фармасьютикалз, Инк. | Твердые дисперсии, содержащие стимулятор sgc |
| SG10202100168XA (en) | 2016-07-07 | 2021-02-25 | Cyclerion Therapeutics Inc | Novel processes for preparation of soluble guanylate cyclase stimulators |
| ES2963563T3 (es) | 2016-07-07 | 2024-03-27 | Cyclerion Therapeutics Inc | Procesos novedosos para preparar estimuladores de guanilato ciclasa soluble |
| EP4249469A3 (en) | 2018-01-10 | 2023-12-27 | Cyclerion Therapeutics, Inc. | Novel processes and intermediates for the preparation of soluble guanylate cyclase stimulators |
-
2019
- 2019-01-10 EP EP23187776.2A patent/EP4249469A3/en active Pending
- 2019-01-10 KR KR1020257010603A patent/KR20250048609A/ko active Pending
- 2019-01-10 CN CN201980017700.2A patent/CN111902410B/zh active Active
- 2019-01-10 AU AU2019206560A patent/AU2019206560B2/en active Active
- 2019-01-10 JO JOP/2020/0165A patent/JOP20200165A1/ar unknown
- 2019-01-10 IL IL314714A patent/IL314714A/en unknown
- 2019-01-10 MA MA051565A patent/MA51565A/fr unknown
- 2019-01-10 CN CN202410363184.1A patent/CN118221665A/zh active Pending
- 2019-01-10 KR KR1020207022640A patent/KR102739727B1/ko active Active
- 2019-01-10 US US16/961,109 patent/US11274096B2/en active Active
- 2019-01-10 MX MX2020007364A patent/MX2020007364A/es unknown
- 2019-01-10 CN CN202410363182.2A patent/CN118184645A/zh active Pending
- 2019-01-10 EP EP19703440.8A patent/EP3737679B1/en active Active
- 2019-01-10 MA MA71753A patent/MA71753A/fr unknown
- 2019-01-10 IL IL275748A patent/IL275748B2/en unknown
- 2019-01-10 SG SG11202006311SA patent/SG11202006311SA/en unknown
- 2019-01-10 WO PCT/US2019/013060 patent/WO2019140095A1/en not_active Ceased
- 2019-01-10 KR KR1020247039985A patent/KR20250002720A/ko active Pending
- 2019-01-10 ES ES19703440T patent/ES2963447T3/es active Active
- 2019-01-10 CA CA3087943A patent/CA3087943A1/en active Pending
- 2019-01-10 JP JP2020538535A patent/JP7357621B2/ja active Active
- 2019-01-10 IL IL319883A patent/IL319883A/en unknown
- 2019-01-10 TW TW112138274A patent/TWI888947B/zh active
- 2019-01-10 TW TW108101044A patent/TWI821237B/zh active
- 2019-01-10 EP EP25174051.0A patent/EP4570797A3/en active Pending
-
2020
- 2020-07-07 CL CL2020001814A patent/CL2020001814A1/es unknown
- 2020-07-13 MX MX2023000045A patent/MX2023000045A/es unknown
- 2020-07-13 MX MX2023000044A patent/MX2023000044A/es unknown
-
2021
- 2021-10-08 US US17/497,352 patent/US11708361B2/en active Active
-
2022
- 2022-04-08 CL CL2022000904A patent/CL2022000904A1/es unknown
- 2022-04-08 CL CL2022000907A patent/CL2022000907A1/es unknown
-
2023
- 2023-04-28 US US18/140,966 patent/US12030874B2/en active Active
- 2023-09-26 JP JP2023162922A patent/JP7744955B2/ja active Active
- 2023-11-22 AU AU2023270260A patent/AU2023270260B2/en active Active
-
2024
- 2024-05-22 US US18/671,182 patent/US12275724B2/en active Active
-
2025
- 2025-03-31 AU AU2025202281A patent/AU2025202281A1/en active Pending
- 2025-04-11 US US19/176,742 patent/US20250361228A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA46479A (fr) | Procédés et intermédiaires pour la préparation de nouveaux composés substitués de 6,7-dihydro-5h-benzo[7]annulène | |
| EP3642217A4 (en) | PROCESS AND INTERMEDIATE PRODUCTS FOR THE MANUFACTURING OF BALIC ACID DERIVATIVES | |
| MA55082A (fr) | Compositions, procédés, et kits pour l'administration de polyribonucléotides | |
| EP3504196A4 (en) | METHOD FOR PRODUCING OLAPARIB | |
| EP3749769A4 (en) | PROCESS FOR THE PREPARATION OF MORPHINE ALKALOIDS AND DERIVATIVES | |
| MA45798A (fr) | Compositions et procédés d'inhibition de masp-3 pour le traitement de maladies et troubles divers | |
| EP3652192A4 (en) | BIOLOGICAL PROCESS FOR THE PRODUCTION OF TERPENS | |
| EP3529232A4 (fr) | Dérivés d'acide sulfamique et procédés pour leur préparation | |
| MA53445A (fr) | Procédés et compositions pour la modification de plantes | |
| EP3893655A4 (en) | METHOD OF PREPARING A PLANT PROTEIN COMPOSITION | |
| EP3645049A4 (en) | MULTISPECIFIC ANTIBODIES AND THE METHOD OF MANUFACTURING AND USING THEREOF | |
| EP3707260A4 (en) | COMPOUNDS AND PROCEDURES FOR REDUCING SNCA EXPRESSION | |
| MA50041A (fr) | Composés spirocycliques et procédés de préparation et d'utilisation de ceux-ci | |
| MA49705A (fr) | Intermédiaires utiles pour la synthèse d'un inhibiteur sélectif vis-à-vis de la protéine kinase et leurs procédés de préparation | |
| EP3488018A4 (en) | METHOD AND COMPOSITIONS FOR PROTEIN IDENTIFICATION | |
| MA71753A (fr) | Nouveaux procédés et intermédiaires pour la préparation de stimulateurs de guanylate cyclase soluble | |
| EP3645529A4 (en) | PROCESS FOR MANUFACTURING LIFITEGRAST AND INTERMEDIATE PRODUCTS THEREOF | |
| EP3432872A4 (en) | COMPOSITIONS AND METHODS FOR USE OF EFLORNITHIN AND DERIVATIVES AND ANALOGUE THEREOF FOR THE TREATMENT OF CANCER, INCLUDING GLIOMEN | |
| EP3429754A4 (en) | SAMPLE PREPARATION CARTRIDGES AND METHOD OF USE THEREOF | |
| MA53370A (fr) | Procédé et intermédiaires pour la préparation de bilastine | |
| EP3481201A4 (en) | METHOD FOR PRODUCING 4-ALKOXY-3- (ACYL OR ALKYL) OXYPICOLINAMIDES | |
| EP3466280A4 (en) | METHOD FOR PRODUCING PROCESSED FOOD AND PROCESSED FOOD PRODUCED BY THIS | |
| MA51307A (fr) | Compositions laitières fermentées et procédés de préparation de celles-ci | |
| MA42497A (fr) | Procédés et compositions pour la régulation sélective de l'expression protéique | |
| EP3570707A4 (en) | FEEDING TIPS, FEEDING CUP AND METHOD FOR USE |